Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|April 4, 1998
Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and childrenL de Repentigny, J Ratelle, J M Leclerc, et al.
Journal of the American Academy of Dermatology|November 1, 1988
Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative studyJ D Stratigos, C Antoniou, A Katsambas, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1988
Itraconazole pharmacokinetics in patients with renal dysfunctionJ Boelaert, M Schurgers, E Matthys, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulationJ W Mouton, A van Peer, K de Beule, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDSP Phillips, K De Beule, G Frechette, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care unitsK Vandewoude, D Vogelaers, J Decruyenaere, et al.
Journal of the American Academy of Dermatology|July 1, 1989
Use of topical ketanserin in the treatment of skin ulcers: a double-blind studyP A Janssen, H Janssen, G Cauwenbergh, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancyM A Boogaerts, J Maertens, R Van Der Geest, et al.
Annals of Internal Medicine|September 19, 2001
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trialM Boogaerts, D J Winston, E J Bow, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2001
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.
Pageof 3